COMPLETE RESPONSE

Clinical trials for COMPLETE RESPONSE explained in plain language.

Never miss a new study

Get alerted when new COMPLETE RESPONSE trials appear

Sign up with your email to follow new studies for COMPLETE RESPONSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New pill may keep ovarian cancer at bay for longer in women with BRCA mutations

Disease control Ongoing

This study tests whether taking olaparib daily after initial chemotherapy can delay the return of advanced ovarian cancer in women with BRCA gene mutations. About 450 women whose cancer responded to platinum-based chemo will receive either olaparib or a placebo. The goal is to se…

Matched conditions: COMPLETE RESPONSE

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated May 17, 2026 05:06 UTC

COMPLETE RESPONSE

Get alerted when new COMPLETE RESPONSE trials appear

New pill may keep ovarian cancer at bay for longer in women with BRCA mutations